M. Kannan

Enhanced In Vitro Wound Healing Using PVA/B-PEI Nanofiber Mats: A Promising Wound Therapeutic Agent against ESKAPE and Opportunistic Pathogens.

S. S. Gorthi, Aarcha Shanmugha Mary, V. Raghavan, 2021, ACS applied bio materials.

SARS-CoV-2 infection- induced growth factors play differential roles in COVID-19 pathogenesis

M. Kannan, R. Halwani, M. Saleh, 2022, Life Sciences.

Lipocalin-2, S100A8/A9, and cystatin C: Potential predictive biomarkers of cardiovascular complications in COVID-19

M. Kannan, R. Halwani, F. Ahmad, 2022, Experimental biology and medicine.

Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants

M. Kannan, E. Shankar, M. Larsson, 2022, Frontiers in Public Health.

TFPI and FXIII negatively and S100A8/A9 and Cystatin C positively correlate with D-dimer in COVID-19

M. Kannan, R. Halwani, R. Qaisar, 2022, Experimental biology and medicine.

Antiviral activity of ethanolic extract of Nilavembu Kudineer against dengue and chikungunya virus through in vitro evaluation

S. Sunil, J. Jain, M. Kannan, 2019, Journal of Ayurveda and integrative medicine.

The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper

Yiannis A. Theodorou, J. Douketis, M. Dimopoulos, 2021, Thrombosis and Haemostasis.

Genomic surveillance of omicron B.1.1.529 SARS‐CoV‐2 and its variants between December 2021 and March 2023 in Tamil Nadu, India—A state‐wide prospective longitudinal study

M. Kannan, E. Shankar, S. Byrareddy, 2024, Journal of medical virology.